Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessregulation of NADP metabolic process

ME2 MTOR

4.44e-061072GO:1902031
GeneOntologyBiologicalProcessNADP metabolic process

ME2 MTOR

1.51e-045672GO:0006739
GeneOntologyBiologicalProcesswound healing

VPS33B FER1L5 MTOR

4.42e-0449373GO:0042060
GeneOntologyBiologicalProcesstransmission of nerve impulse

OTOA MTOR

6.03e-0411272GO:0019226
GeneOntologyBiologicalProcessregulation of purine nucleotide metabolic process

ME2 MTOR

6.03e-0411272GO:1900542
GeneOntologyBiologicalProcessregulation of nucleotide metabolic process

ME2 MTOR

6.14e-0411372GO:0006140
GeneOntologyBiologicalProcesslytic vacuole organization

VPS33B MTOR

6.80e-0411972GO:0080171
GeneOntologyBiologicalProcesslysosome organization

VPS33B MTOR

6.80e-0411972GO:0007040
GeneOntologyBiologicalProcessregulation of cell-cell adhesion

VPS33B MYO10 MTOR

7.11e-0458073GO:0022407
GeneOntologyBiologicalProcesspyruvate metabolic process

ME2 MTOR

9.66e-0414272GO:0006090
GeneOntologyBiologicalProcessvesicle fusion

VPS33B FER1L5

9.66e-0414272GO:0006906
GeneOntologyBiologicalProcessorganelle membrane fusion

VPS33B FER1L5

9.93e-0414472GO:0090174
GeneOntologyBiologicalProcessresponse to wounding

VPS33B FER1L5 MTOR

1.03e-0365973GO:0009611
GeneOntologyBiologicalProcessorganelle fusion

VPS33B FER1L5

1.72e-0319072GO:0048284
GeneOntologyBiologicalProcessnicotinamide nucleotide metabolic process

ME2 MTOR

1.94e-0320272GO:0046496
GeneOntologyBiologicalProcesspyridine nucleotide metabolic process

ME2 MTOR

1.94e-0320272GO:0019362
GeneOntologyBiologicalProcesspyridine-containing compound metabolic process

ME2 MTOR

2.09e-0321072GO:0072524
GeneOntologyBiologicalProcessmembrane fusion

VPS33B FER1L5

2.11e-0321172GO:0061025
GeneOntologyBiologicalProcessregulation of cell adhesion

VPS33B MYO10 MTOR

2.76e-0392773GO:0030155
GeneOntologyBiologicalProcessregulation of plasma membrane bounded cell projection assembly

MYO10 MTOR

2.91e-0324872GO:0120032
GeneOntologyBiologicalProcessvacuole organization

VPS33B MTOR

2.93e-0324972GO:0007033
GeneOntologyBiologicalProcessmulticellular organism growth

OTOA MTOR

2.93e-0324972GO:0035264
GeneOntologyBiologicalProcessregulation of cell projection assembly

MYO10 MTOR

2.98e-0325172GO:0060491
GeneOntologyBiologicalProcessmuscle cell development

FER1L5 MTOR

3.16e-0325972GO:0055001
GeneOntologyBiologicalProcessphagocytosis

VPS33B FER1L5

3.53e-0327472GO:0006909
GeneOntologyBiologicalProcesscell-cell adhesion

VPS33B MYO10 MTOR

4.24e-03107773GO:0098609
GeneOntologyBiologicalProcessleukocyte activation involved in immune response

FER1L5 MTOR

6.05e-0336172GO:0002366
GeneOntologyCellularComponentlysosome

DPP7 VPS33B MTOR

1.81e-0381173GO:0005764
GeneOntologyCellularComponentlytic vacuole

DPP7 VPS33B MTOR

1.81e-0381173GO:0000323
GeneOntologyCellularComponentvacuole

DPP7 VPS33B MTOR

2.55e-0391373GO:0005773
GeneOntologyCellularComponentsynaptic vesicle

VPS33B FER1L5

4.11e-0330072GO:0008021
GeneOntologyCellularComponentexocytic vesicle

VPS33B FER1L5

4.66e-0332072GO:0070382
GeneOntologyCellularComponentsecretory vesicle

DPP7 VPS33B FER1L5

6.17e-03124673GO:0099503
Pubmed

Proteomic identification of brain proteins that interact with dynein light chain LC8.

ME2 MYO10

2.98e-05427214760703
CoexpressionGSE19825_NAIVE_VS_IL2RAHIGH_DAY3_EFF_CD8_TCELL_DN

DPP7 VPS33B MTOR

1.50e-0520073M4300
CoexpressionFAN_OVARY_CL11_MURAL_GRANULOSA_CELL

DPP7 ME2 MYO10

1.61e-0444473M41713
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

DPP7 OTOA

1.78e-054272b0ebd9d2456e4bab44e91b35d728224da6a052ea
ToppCellTracheal-10x3prime_v2-Immune_Lymphocytic-B-B_cell-B_naive|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations

VPS33B MTOR

1.04e-041017286acaa2502f61baa714ae988b73e3e73a71e897e
ToppCellE18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

DPP7 ME2

2.54e-0415872f61ebe3a316e4259387cd9da83707f15e6473cae
ToppCellCOVID-mono3|COVID / Condition, Cell_class and T cell subcluster

OTOA MYO10

2.71e-04163726ab4cbcd411b40920b81162c0f4b03ea67408f52
ToppCellCOVID-mono3-|COVID / Condition, Cell_class and T cell subcluster

OTOA MYO10

2.71e-041637226661c7a3a0a449ed32d4b3b28fc2fc0b237025d
ToppCell3'-GW_trimst-2-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

OTOA MYO10

3.37e-04182720346f81bbb1f309f3e9d063b20547d548d09472c
ToppCellMesenchymal_cells-Osteoblasts|Mesenchymal_cells / Lineage and Cell class

ME2 MYO10

3.41e-0418372d6b52d52fe9a7a6c798947f05420d79fe12e4662
ToppCell10x5'-bone_marrow-Myeloid_Mac-Erythrophagocytic_macrophages|bone_marrow / Manually curated celltypes from each tissue

OTOA ME2

3.67e-04190729db04555c98eca1df15d144fbb499e0ba06660d5
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

OTOA ME2

3.99e-04198725aaf3861c53763cf09bb628c9d2eabb6a7277021
ToppCell356C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells)

DPP7 OTOA

3.99e-04198723b4611c9ee4d42e042a29ddb4580a95938d87d65
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid-myeloid_macrophage|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

OTOA ME2

3.99e-04198729aaff68107ae4542f904b142d23669f2fcd557ac
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac|lymph-node_spleen / Manually curated celltypes from each tissue

OTOA ME2

4.03e-0419972c051cc3e42cfa2ec09fd8dae1172af350bb2dfcb
ToppCell10x5'-Liver-Myeloid_Mac-Erythrophagocytic_macrophages|Liver / Manually curated celltypes from each tissue

OTOA ME2

4.03e-0419972600afac424416268766fc5c051d4c62ab9eef5de
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac-Erythrophagocytic_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue

OTOA ME2

4.03e-041997278db2e3b85356ed2f08794e5a97c16a220f8a076
ToppCell10x5'-Liver-Myeloid_Mac|Liver / Manually curated celltypes from each tissue

OTOA ME2

4.03e-0419972aed138ee879e4e625f177c5bfe0f857a335eb6f2
ToppCellCOVID-19-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class

DPP7 OTOA

4.07e-0420072a60346c5ea7a3dae1ad3c5dc6c6eca65b64c6888
ToppCellmetastatic_Brain-Myeloid_cells-mo-Mac|metastatic_Brain / Location, Cell class and cell subclass

OTOA ME2

4.07e-04200728f702d518f652782b0dd6ca3bdd965a79deb61f3
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Macroglial|6m / Sample Type, Dataset, Time_group, and Cell type.

DPP7 MYO10

4.07e-042007242dc8ed66a021097e703eef2d756607396ca2f56
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial|6_mon / Sample Type, Dataset, Time_group, and Cell type.

DPP7 MYO10

4.07e-0420072fff209256805a448393c385b79a70c2e2172e49c
ToppCellmetastatic_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass

DPP7 ME2

4.07e-0420072bfb54a8ce44caf01083c6567b236395c6ee1d47a
ToppCellBrain_organoid-organoid_Tanaka_cellReport-6m-Macroglial-Astrocyte|6m / Sample Type, Dataset, Time_group, and Cell type.

DPP7 MYO10

4.07e-04200726ff22adb3007c3c9ef64a05c9dbc1d440bdaee1b
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-6_mon-Radial_glial-RG|6_mon / Sample Type, Dataset, Time_group, and Cell type.

DPP7 MYO10

4.07e-0420072fb7c9c0e4beadad6e41e68f6f889e56650898d22
DrugNSC99363

MYO10 MTOR

3.20e-049072CID000414014
Drugblebbistatin

MYO10 MTOR

5.31e-0411672CID003476986
DrugAC1LCVTP

MYO10 MTOR

5.50e-0411872CID000656983
DrugNVP & EFV

DPP7 MTOR

5.78e-0412172CID000492400
Drugm189

ME2 MTOR

1.24e-0317872CID000022230
DrugAcetylcysteine

OTOA FER1L5 MTOR

1.26e-0378073ctd:D000111
DrugRicinine [524-40-3]; Down 200; 24.4uM; HL60; HT_HG-U133A

MYO10 MTOR

1.46e-03193722505_DN
DrugOxybutynin chloride [1508-65-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.47e-03194723168_DN
DrugTetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.49e-03195726233_DN
DrugCefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.50e-03196722843_DN
DrugConvolamine hydrochloride [500-56-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.52e-03197727230_DN
DrugMeglumine [6284-40-8]; Down 200; 20.4uM; HL60; HT_HG-U133A

VPS33B MYO10

1.52e-03197723068_DN
DrugTrioxsalen [3902-71-4]; Down 200; 17.6uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.52e-03197726216_DN
DrugClofazimine [2030-63-9]; Up 200; 8.4uM; HL60; HG-U133A

VPS33B MYO10

1.54e-03198721624_UP
DrugHarmane hydrochloride [21655-84-5]; Up 200; 18.2uM; HL60; HT_HG-U133A

MYO10 MTOR

1.54e-03198722150_UP
Drug(1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Down 200; 11.8uM; PC3; HT_HG-U133A

VPS33B MTOR

1.54e-03198724546_DN
DrugErgocryptine-alpha [511-09-1]; Down 200; 7uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.54e-03198723900_DN
DrugIobenguane sulfate; Down 200; 10.8uM; MCF7; HT_HG-U133A

MYO10 MTOR

1.55e-03199726002_DN
DrugPseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A

VPS33B MYO10

1.55e-03199727184_DN
DrugIsopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; PC3; HT_HG-U133A

VPS33B MTOR

1.55e-03199725879_DN

Protein segments in the cluster

PeptideGeneStartEntry
DFFLAHFQDFQNNFA

OTOA

596

Q7RTW8
FGFENFEVNHFEQFN

MYO10

436

Q9HD67
FEVNHFEQFNINYAN

MYO10

441

Q9HD67
LIQFEDFGNHNAFRF

ME2

251

P23368
FQERFFQQRLDHFNF

DPP7

31

Q9UHL4
TFFFQQVQPFFDNIF

MTOR

181

P42345
NPFFNEIFFQNFHEV

FER1L5

206

A0AVI2
FNEIRNEHFSNVFGF

VPS33B

286

Q9H267